Trials / Completed
CompletedNCT05954065
An Evaluation of the Effect of the Erchonia Laser for Non-invasive Reduction of Submental Fat
An Evaluation of the Effect of the Erchonia Corporation CFL Laser for Non-invasive Reduction of Submental Fat
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Erchonia Corporation · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® CFL (manufactured by Erchonia Corporation (the Company), in providing noninvasive fat reduction in the submental area.
Detailed description
This clinical study is a prospective open-label design with post-study independent blinded outcome analysis to evaluate the efficacy of the Erchonia® CFL Laser in providing a noninvasive fat reduction in the submental area. Participants will receive 8 treatments over the course of 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Erchonia CFL Laser | 405nm violet and 520nm green laser light therapy. |
Timeline
- Start date
- 2023-07-12
- Primary completion
- 2024-05-31
- Completion
- 2024-09-30
- First posted
- 2023-07-20
- Last updated
- 2025-08-29
- Results posted
- 2025-08-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05954065. Inclusion in this directory is not an endorsement.